These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8418210)

  • 1. Site-specific alterations in the B oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin.
    Lobet Y; Feron C; Dequesne G; Simoen E; Hauser P; Locht C
    J Exp Med; 1993 Jan; 177(1):79-87. PubMed ID: 8418210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of pertussis toxin analogs containing mutations in B-oligomer subunits.
    Loosmore S; Zealey G; Cockle S; Boux H; Chong P; Yacoob R; Klein M
    Infect Immun; 1993 Jun; 61(6):2316-24. PubMed ID: 8500874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic exchange of the S2 and S3 subunits in pertussis toxin.
    Raze D; Veithen A; Sato H; Antoine R; Menozzi FD; Locht C
    Mol Microbiol; 2006 Jun; 60(5):1241-50. PubMed ID: 16689799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADP-ribosyltransferase activity of pertussis toxin and immunomodulation by Bordetella pertussis.
    Black WJ; Munoz JJ; Peacock MG; Schad PA; Cowell JL; Burchall JJ; Lim M; Kent A; Steinman L; Falkow S
    Science; 1988 Apr; 240(4852):656-9. PubMed ID: 2896387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ins and outs of pertussis toxin.
    Locht C; Coutte L; Mielcarek N
    FEBS J; 2011 Dec; 278(23):4668-82. PubMed ID: 21740523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of amino acid residues essential for the enzymatic activities of pertussis toxin.
    Locht C; Capiau C; Feron C
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3075-9. PubMed ID: 2470088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of mutant strains producing pertussis toxin cross reacting materials.
    Sato Y; Sato H; Chazono M; Ginnaga A; Tamura C
    Dev Biol Stand; 1991; 73():93-107. PubMed ID: 1778339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pertussis holotoxoid formed in vitro with a genetically deactivated S1 subunit.
    Bartley TD; Whiteley DW; Mar VL; Burns DL; Burnette WN
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8353-7. PubMed ID: 2554311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of complete and truncated forms of pertussis toxin subunits S1 and S2 synthesized by Escherichia coli.
    Locht C; Cieplak W; Marchitto KS; Sato H; Keith JM
    Infect Immun; 1987 Nov; 55(11):2546-53. PubMed ID: 3117686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope.
    Burnette WN; Cieplak W; Mar VL; Kaljot KT; Sato H; Keith JM
    Science; 1988 Oct; 242(4875):72-4. PubMed ID: 2459776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The subunit S1 is important for pertussis toxin secretion.
    Pizza M; Bugnoli M; Manetti R; Covacci A; Rappuoli R
    J Biol Chem; 1990 Oct; 265(29):17759-63. PubMed ID: 2211659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of linear B-cell determinants of pertussis toxin associated with the receptor recognition site of the S3 subunit.
    Schmidt MA; Raupach B; Szulczynski M; Marzillier J
    Infect Immun; 1991 Apr; 59(4):1402-8. PubMed ID: 1706321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The crystal structure of pertussis toxin.
    Stein PE; Boodhoo A; Armstrong GD; Cockle SA; Klein MH; Read RJ
    Structure; 1994 Jan; 2(1):45-57. PubMed ID: 8075982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of pertussis toxin binding to model receptors by antipeptide antibodies directed at an antigenic domain of the S2 subunit.
    Schmidt MA; Schmidt W
    Infect Immun; 1989 Dec; 57(12):3828-33. PubMed ID: 2478479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of monoclonal antibody to pertussis toxin on toxin activity.
    Sato H; Sato Y; Ito A; Ohishi I
    Infect Immun; 1987 Apr; 55(4):909-15. PubMed ID: 2435660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural relationship between the S1 and S4 subunits of pertussis toxin.
    Sato H; Sato Y
    FEMS Microbiol Lett; 1994 Jan; 115(1):63-9. PubMed ID: 7510256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and immunological characterization of HPLC-purified pertussis toxin subunits.
    Chong P; Cockle S; Boux H; Klein M
    Biochem Cell Biol; 1991; 69(5-6):336-40. PubMed ID: 1654940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subunit S1 of pertussis toxin: mapping of the regions essential for ADP-ribosyltransferase activity.
    Pizza M; Bartoloni A; Prugnola A; Silvestri S; Rappuoli R
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7521-5. PubMed ID: 2902632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assignment of functional domains involved in ADP-ribosylation and B-oligomer binding within the carboxyl terminus of the S1 subunit of pertussis toxin.
    Krueger KM; Barbieri JT
    Infect Immun; 1994 May; 62(5):2071-8. PubMed ID: 8168972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen.
    Kimura A; Mountzouros KT; Schad PA; Cieplak W; Cowell JL
    Infect Immun; 1990 Oct; 58(10):3337-47. PubMed ID: 2119344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.